We are live on ! Find out more
AHCO icon

AdaptHealth

193 hedge funds and large institutions have $2.04B invested in AdaptHealth in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 68 increasing their positions, 70 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

321% more call options, than puts

Call options by funds: $45.2M | Put options by funds: $10.7M

61% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 18

5% more capital invested

Capital invested by funds: $1.94B → $2.04B (+$104M)

5% more funds holding

Funds holding: 184193 (+9)

2.15% more ownership

Funds ownership: 76.69%78.84% (+2.2%)

3% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 70

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
193
Holders Change
+9
Holders Change %
+4.89%
% of All Funds
3.1%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
29
Increased
68
Reduced
70
Closed
18
Calls
$45.2M
Puts
$10.7M
Net Calls
+$34.5M
Net Calls Change
-$6.03M
Name Holding Trade Value Shares
Change
Change in
Stake
OCA
1
OEP Capital Advisors
New York
$266M
BlackRock
2
BlackRock
New York
$228M -$1.05M -49,857 -0.4%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$182M +$19.3M +913,470 +11%
SC
4
SkyKnight Capital
California
$171M
Vanguard Group
5
Vanguard Group
Pennsylvania
$158M +$8.81M +416,567 +5%
DM
6
Deerfield Management
New York
$147M -$12.6M -596,622 -7%
Truist Financial
7
Truist Financial
North Carolina
$75.7M +$74.4M +3,518,459 +834%
RCMNY
8
Rubric Capital Management (New York)
New York
$72.5M +$414K +19,572 +0.5%
Sumitomo Mitsui Trust Group
9
Sumitomo Mitsui Trust Group
Japan
$57.2M +$1.27M +59,972 +2%
State Street
10
State Street
Massachusetts
$48M -$5.04M -238,352 -9%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$36.9M -$6.74M -318,942 -14%
SAM
12
Silvercrest Asset Management
New York
$33.7M -$20.9M -989,612 -36%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$28.5M +$728K +34,452 +2%
Ameriprise
14
Ameriprise
Minnesota
$26.8M -$167K -7,878 -0.6%
MC
15
Maverick Capital
Texas
$26.8M
Bank of America
16
Bank of America
North Carolina
$25.3M +$18.8M +888,995 +208%
JP Morgan Chase
17
JP Morgan Chase
New York
$24.3M -$390K -18,440 -1%
PCM
18
Palisade Capital Management
New Jersey
$23.2M -$591K -27,968 -2%
EA
19
Emerald Advisers
Pennsylvania
$21.7M +$3.44M +162,885 +17%
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$19.3M +$1.97M +93,374 +10%
Amundi
21
Amundi
France
$18.8M +$236K +11,163 +1%
EMFAT
22
Emerald Mutual Fund Advisers Trust
Pennsylvania
$16.5M +$3.34M +157,978 +23%
Northern Trust
23
Northern Trust
Illinois
$16.2M +$912K +43,143 +5%
KCM
24
Kennedy Capital Management
Missouri
$15.8M +$3.52M +166,709 +26%
Millennium Management
25
Millennium Management
New York
$15.1M +$13.6M +645,281 +458%

AHCO Hedge Fund Activity: Q4 2022 in Review

193 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q4 2022, worth a combined $2.04B — up 5.4% from $1.94B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new AHCO positions and 18 closed out — a net gain of 11 holders — while 68 added to existing stakes and 70 trimmed.

The largest buyer was Truist Financial, adding an estimated $74.4M. The largest seller was Silvercrest Asset Management, cutting an estimated $20.9M.

  • 193 institutional investors held AdaptHealth (AHCO) as of Q4 2022, up from 184 in Q3 2022.
  • Funds reported $2.04B of AdaptHealth stock for Q4 2022, up 5.4% quarter-over-quarter.
  • 29 funds opened new AdaptHealth positions in Q4 2022 and 18 closed out, a net change of +11 holders.
  • The largest AdaptHealth buyer in Q4 2022 was Truist Financial, an estimated $74.4M added.
  • The largest AdaptHealth seller in Q4 2022 was Silvercrest Asset Management, an estimated $20.9M sold.

Based on aggregated 13F filings for Q4 2022.